UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,000 | +160.0% | 189 | +58.8% | 0.00% | – |
Q3 2019 | $5,000 | -37.5% | 119 | +15.5% | 0.00% | – |
Q2 2019 | $8,000 | +33.3% | 103 | +3.0% | 0.00% | – |
Q1 2019 | $6,000 | -96.2% | 100 | -98.2% | 0.00% | -100.0% |
Q4 2018 | $159,000 | -12.6% | 5,500 | +10.0% | 0.00% | -50.0% |
Q3 2018 | $182,000 | +21.3% | 5,000 | -21.9% | 0.00% | +100.0% |
Q2 2018 | $150,000 | 0.0% | 6,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $150,000 | +354.5% | 6,400 | +276.5% | 0.00% | – |
Q4 2017 | $33,000 | +266.7% | 1,700 | +229.5% | 0.00% | – |
Q4 2015 | $9,000 | +200.0% | 516 | +209.0% | 0.00% | – |
Q3 2015 | $3,000 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |